Lijie Ma | Liver Immunology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Lijie Ma | Liver Immunology | Research Excellence Award

Renji Hospital Shanghai Jiao Tong University School of Medicine | China

Dr. Lijie Ma is a clinician-scientist at Fudan University, Shanghai, China, with recognized expertise in surgical oncology, particularly in the management of retroperitoneal sarcoma, hepatobiliary tumors, and complex oncologic surgery. His scholarly work is widely cited and demonstrates sustained influence in high-impact surgical and medical journals. Dr. Ma’s research emphasizes multidisciplinary care models, outcome-driven surgical strategies, and translational approaches, including single-cell analysis, to better understand tumor progression and metastatic mechanisms. He is an active participant in extensive national and international collaborations, contributing to the development of standardized, evidence-based clinical practices. Through the integration of advanced research methodologies and real-world clinical data, Dr. Ma’s work supports improved patient care, optimized surgical outcomes, and meaningful advances in modern cancer management with broad societal relevance.

Citation Metrics (Scopus)

2866
2200
1600
800
0

Citations

2,866

Documents

43

h-index

26

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Ani Ioana Cotar | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ani Ioana Cotar | Immunology | Best Researcher Award

PhD, senior researcher at Cantacuzino Research Institute, Romania.

Dr. Ani Ioana Cotar is a distinguished research scientist and head of the National Center for Expertise and Intervention in Public Health for Biological, Chemical, Radiological, and Nuclear Agents at the “Cantacuzino” National Medico-Military Institute in Bucharest, Romania. Her career spans over 20 years, specializing in virology and vector-borne infections, including high-impact diseases such as West Nile, Zika, and Chikungunya viruses. Her expertise in molecular diagnostics and pathogen characterization has positioned her at the forefront of infectious disease research, with extensive experience in immunology and molecular biology techniques. Dr. Cotar’s significant role in global health initiatives is underscored by her work with the EVDLabNet and WHO in external quality assurance (EQA) schemes. Her commitment to advancing public health and her innovative research approaches make her a prominent figure in the field, with her contributions directly impacting diagnostic accuracy and understanding of viral pathogen epidemiology.

Professional Profile

Education

Dr. Cotar’s educational background includes a Ph.D. in Biology from the Faculty of Biology, University of Bucharest, completed in 2009. She holds an MSc in Genetics from the same institution and a BSc in Biology. Additionally, she completed two postdoctoral fellowships; one at the University of Bucharest, where she deepened her understanding of molecular biology, and the other under the European Program for Public Health Microbiology (EUPHEM) in Stockholm. This extensive education laid the groundwork for her career in vector-borne infections and public health. Her advanced studies, particularly in molecular epidemiology, prepared her for her pioneering role in pathogen identification and control. Dr. Cotar’s academic accomplishments highlight her commitment to integrating science with public health practices to improve diagnostic protocols and preventive strategies against infectious diseases.

Professional Experience

Dr. Cotar began her career at the “Cantacuzino” Institute in 2001 as a biologist and progressed to roles of increasing responsibility, becoming a Research Scientist I by 2022 and Head of the National Center in 2023. Her experience includes leading projects on the molecular diagnostics of high-risk vector-borne pathogens and implementing quality assurance testing for the WHO. Her work includes crucial contributions to SARS-CoV-2 diagnostics during the pandemic and coordinating whole-genome sequencing for bacterial pathogens. She has developed protocols for DNA/RNA extraction, PCR, and real-time PCR, bringing rigorous scientific standards to her laboratory’s practices. Her leadership and technical expertise have contributed to significant advancements in Romania’s capacity to detect, monitor, and respond to infectious disease threats, particularly in vector-borne pathogens affecting both national and global health landscapes.

Research Interest

Dr. Cotar’s research interests lie in the molecular epidemiology and diagnostics of viral and bacterial vector-borne pathogens. Her work focuses on identifying and characterizing infectious agents such as West Nile, Zika, and Chikungunya viruses, as well as bacterial pathogens like Rickettsia and Borrelia. She is committed to improving diagnostic capabilities through molecular biology techniques, including PCR, DNA sequencing, and bioinformatics. Dr. Cotar’s research extends to quality assurance, participating in global quality initiatives that enhance laboratory accuracy for pathogen detection. Her expertise in molecular typing and genome sequencing reflects her focus on understanding pathogen transmission, evolution, and resistance, critical for developing effective public health interventions.

Award and Honor

Dr. Cotar has been recognized for her contributions to public health and infectious disease research. Her work on the frontlines of SARS-CoV-2 diagnostics and her efforts to establish protocols for emerging viral and bacterial pathogens have earned her respect within the scientific community. She has received accolades for her role in quality assurance initiatives with the WHO and her contributions to the EVDLabNet. These recognitions underscore her commitment to improving diagnostic accuracy and public health response capabilities, and her dedication has positioned her as an authority in virology and infectious disease research in Romania and beyond.

Conclusion

Dr. Cotar’s deep specialization in vector-borne infectious diseases, coupled with her proven track record in molecular diagnostics and quality assurance, establishes her as a leading candidate for the Best Researcher Award. Her consistent contributions are essential to advancing both national and global health research on infectious diseases.

Publications top noted

Title: Increasing the Awareness of Under-Diagnosed Tropical Cases of Dengue in Romania
Authors: Cismaru, I.M., Radu, M.A., Cotar, A.I., Ghemulet, I., Gheorghita, V.
Year: 2023
Citation: Tropical Medicine and Infectious Disease, 2023, 8(10), 469.

Title: First Detection and Molecular Characterization of Usutu Virus in Culex pipiens Mosquitoes Collected in Romania
Authors: Prioteasa, F.L., Dinu, S., Tiron, G.V., Ceianu, C.S., Cotar, A.I.
Year: 2023
Citation: Microorganisms, 2023, 11(3), 684.

Title: Distribution of Insecticide Resistance Genetic Markers in the West Nile Virus Vector Culex pipiens from South-Eastern Romania
Authors: Stancu, I.G., Prioteasa, F.L., Tiron, G.V., Ceianu, C.S., Csutak, O.
Year: 2022
Citation: Insects, 2022, 13(11), 1062.

Title: Original Contributions to the Chemical Composition, Microbicidal, Virulence-Arresting, and Antibiotic-Enhancing Activity of Essential Oils from Four Coniferous Species
Authors: Visan, D.-C., Oprea, E., Radulescu, V., Chifiriuc, M.C., Marinas, I.C.
Year: 2021
Citation: Pharmaceuticals, 2021, 14(11), 1159.

Title: Characterization and Host-Feeding Patterns of Culex pipiens s.l. Taxa in a West Nile Virus-Endemic Area in Southeastern Romania
Authors: Tiron, G.V., Stancu, I.G., Dinu, S., Ceianu, C.S., Cotar, A.I.
Year: 2021
Citation: Vector-Borne and Zoonotic Diseases, 2021, 21(9), pp. 713–719.

Title: Emergence of Toscana Virus, Romania, 2017-2018
Authors: Popescu, C.P., Cotar, A.I., Dinu, S., Ceianu, C.S., Florescu, S.A.
Year: 2021
Citation: Emerging Infectious Diseases, 2021, 27(5), pp. 1482–1485.

Title: Increased Risk of Chikungunya Infection in Travelers to Thailand During Ongoing Outbreak in Tourist Areas: Cases Imported to Europe and the Middle East, Early 2019
Authors: Javelle, E., Florescu, S.-A., Asgeirsson, H., Hamer, D.H., Gautret, P.
Year: 2019
Citation: Eurosurveillance, 2019, 24(10), 1900146.

Title: West Nile Virus Lineage 2 in Romania, 2015-2016: Co-Circulation and Strain Replacement
Authors: Cotar, A.I., Fǎlcuţǎ, E., Dinu, S., Ceianu, C.S., Prioteasa, F.L.
Year: 2018
Citation: Parasites and Vectors, 2018, 11(1), 562.

Title: Re-Emergence of Severe West Nile Virus Neuroinvasive Disease in Humans in Romania, 2012 to 2017 – Implications for Travel Medicine
Authors: Popescu, C.P., Florescu, S.A., Cotar, A.I., Ceausu, E., Ruta, S.M.
Year: 2018
Citation: Travel Medicine and Infectious Disease, 2018, 22, pp. 30–35.

Title: Lack of Zika Virus Antibody Response in Confirmed Patients in Non-Endemic Countries
Authors: Lustig, Y., Cotar, A.I., Ceianu, C.S., Aarons, E., Reusken, C.
Year: 2018
Citation: Journal of Clinical Virology, 2018, 99-100, pp. 31–34.

Shanaz sharaf | Immunology and histopathology | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Shanaz sharaf | Immunology and histopathology | Best Researcher Award

PhD Scholar of Regional Cancer Centre, India

Mrs. Shanaz Sharaf is a dedicated researcher with 7 years of experience in biotechnology, biomedical sciences, cell and molecular biology, and clinical research. 🎓 Her work primarily focuses on understanding prognostic tumor markers in Triple Negative Breast Cancer (TNBC), exploring molecular and cell signaling aspects in tumorigenesis, and developing innovative technologies for cancer detection. 🧬 Passionate about advancing cancer research, Mrs. Sharaf is committed to creating novel multiplex technologies for tumor tissue imaging. She aims to leverage her skills and knowledge in a collaborative environment to contribute to cutting-edge scientific advancements and gain exposure to emerging technologies. 🌟

Professional profile

Education📚

Mrs. Shanaz Sharaf holds a Doctor of Philosophy (Ph.D.) in Biotechnology from Manipal Academy of Higher Education, India, where she conducted research on prognostic markers and multiplex platforms for breast cancer classification. 📚 Her academic journey includes a Master of Science in Biotechnology from the University of Kerala, graduating with first-class honors and a distinction of 75.05%. 🎓 Prior to that, she earned a Bachelor of Science in Botany and Biotechnology from the University of Kerala, also with first-class honors and a notable 74.05%. 🌟 Her educational background equips her with a strong foundation in biotechnological and biomedical sciences, essential for her research endeavors.

Professional Experience🏛️

Mrs. Shanaz Sharaf brings a wealth of experience to her field, having served as a PhD Scholar at the Regional Cancer Centre, Thiruvananthapuram, Kerala, India, from 2019 to 2024. 🎓 Her research focused on identifying prognostic markers and developing multiplex platforms for breast cancer classification under the guidance of Dr. K Sujathan. 🧬 Prior to her PhD, she worked as a Junior Research Fellow on translational research in Triple Negative Breast Cancer (2017-2019) and investigated maternal sleep deprivation effects on offspring cognition (2014-2015) at SCTIMST, Thiruvananthapuram. 🔬 Her extensive research background showcases her expertise in molecular and cell biology, particularly in cancer research and innovative diagnostic techniques. 🧪

Research Interest🌐

Mrs. Shanaz Sharaf’s research interests lie in the intersection of biotechnology and cancer research. 🔬 Her primary focus is on understanding the role of prognostic tumor markers in Triple Negative Breast Cancer (TNBC), aiming to enhance disease outcome predictions and improve detection methods. 🧬 She explores various molecular and cell signaling pathways involved in tumorigenesis and is passionate about developing novel multiplex technologies for tumor tissue imaging. 🧪 Her work seeks to innovate cancer detection and treatment, leveraging cutting-edge techniques to advance the field of oncology. 🌟

Awards and Honors🏆

Mrs. Shanaz Sharaf has received notable recognition for her contributions to cancer research and biotechnology. 🏅 Her commitment to advancing the field has been acknowledged through various awards and honors. 🎖️ These accolades highlight her innovative work and dedication, reflecting her impact on the scientific community and her role in pioneering new approaches to cancer detection and treatment. 🌟 Her achievements underscore her excellence and commitment to improving health outcomes through research and innovation. 🌺

Achievements🏅
  • 🎓 Doctoral Research: Completed a Ph.D. in Biotechnology at Manipal Academy of Higher Education, focusing on identifying prognostic markers and developing multiplex platforms for breast cancer classification.
  • 🧬 Research Contributions: Significant work in Triple Negative Breast Cancer, including translational research and novel strategies in cancer detection.
  • 🔬 Conference Organization: Actively involved in organizing major conferences like the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research (2019) and the National Conference on ETHB (2023).
  • 📚 Research Experience: Junior Research Fellow (JRF) with projects on maternal sleep deprivation effects and translational research in breast cancer.
  • 🏆 Professional Recognition: Contributed to significant research advancements and gained recognition within the scientific community for her innovative approaches and findings.
  • 💡 Innovative Technologies: Development of innovative multiplex technologies for tumor tissue imaging, enhancing cancer research methodologies.
Projects🛠️
  • 🔍 Prognostic Markers in Breast Cancer: Identified a panel of prognostic markers and developed a multiplex platform for histoclinical classification of breast cancer during her Ph.D. research at the Regional Cancer Centre.
  • 🧬 Triple Negative Breast Cancer: Conducted translational research focusing on the role of various prognostic tumor markers in Triple Negative Breast Cancer.
  • 🧪 Maternal Sleep Deprivation Study: Investigated the effects of maternal sleep deprivation on cognition in offspring using an animal model during her tenure as a Junior Research Fellow.
  • 🧩 Tumor Tissue Imaging: Worked on developing innovative multiplex technologies for enhanced imaging of tumor tissues.
  • 🗂️ Conference Organization: Played a key role in organizing major conferences, including the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research and the National Conference on ETHB.
Publications top noted📜
  • 📄 “Subcellular expression of MTA1, HIF1A, and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study”
    • Authors: Sharaf, S.S., Jaganath Krishna, K.M., Lekshmi, A., Sujathan
    • Journal: Journal of Molecular Histology
    • Year: 2024
    • Volume: 55
    • Issue: 3
    • Pages: 303–315
    • Citations: 0
  • 📄 “A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor – Quantum dot conjugates and a panel of chromogenic dyes”
    • Authors: Sharaf, S.S., Lekshmi, A., S, A., Santhosh Kumar, T.R., K, S.
    • Journal: Pathology Research and Practice
    • Year: 2024
    • Volume: 253
    • Article: 155033
    • Citations: 1

Jean-nicolas boursiquot | Immunology | Best Researcher Award

Published on by Global Scholar Awards

🌟Dr. Jean-nicolas boursiquot, Immunology, Best Researcher Award 🏆

  •  Doctorate at CHU de Quebec, Canada
 

Jean-Nicolas Boursiquot is a highly qualified medical professional specializing in allergy and clinical immunology. With a comprehensive educational background and extensive research experience, Boursiquot has made significant contributions to the field through publications, presentations, and teaching activities. His dedication to advancing medical knowledge and patient care is evident in his multifaceted professional journey, marked by numerous affiliations, academic commitments, and media engagements. Boursiquot’s expertise encompasses a wide range of topics within allergy and immunology, making him a respected figure in both academic and clinical settings.

Author Metrics:

Scopus Profile

Boursiquot’s author metrics reflect a prolific and impactful academic career, with a substantial number of publications in peer-reviewed journals, presentations at scientific conferences, and media engagements.

  • Citations: 385 citations by 385 documents
  • Documents: 9
  • h-index: 5

Education:

  • Ph.D. in Medicine (M.D.), Laval University, Quebec, Canada, 1999-2004
  • Intensive ESL (English as Second Language) Training, University of Manitoba, Winnipeg, Canada, 1999
  • International Baccalaureate (Pure Sciences), Small Seminary of Quebec, Quebec, Canada, 1997-1999

Research Focus:

Boursiquot’s research focuses primarily on allergy and clinical immunology, with particular interests in immunodeficiencies, allergic rhinitis, asthma, drug allergies, and angioedema. He has conducted studies on various aspects of these conditions, contributing to advancements in diagnosis, treatment, and understanding of underlying mechanisms.

Professional Journey:

Boursiquot’s professional journey spans diverse roles in academia, clinical practice, research, and education:

  • Clinical Allergist and Immunologist at CSSS DES ILES and CSSS DE LAC-SAINT-JEAN-EST
  • Clinical Professor and Educational Ambassador at Laval University
  • Member of various professional committees and boards, including the Canadian Society of Allergy and Clinical Immunology (CSACI) and the Association of Allergists and Immunologists of Quebec (AAIQ)
  • Active involvement in medical education and training, including teaching medical students, residents, and clinicians

Honors & Awards:

  • Recipient of the CMDP of CHUQ and CHUQ-CMDP Foundation Award in 2010
  • Awarded the Humanism Prize in 1997 by the Small Seminary of Quebec

Research Timeline:

1999-2004: Pursued Ph.D. in Medicine at Laval University, Quebec, Canada

2007-2009: Completed Residency in Allergy and Clinical Immunology at McGill University, Montreal, Canada

2010: Conducted Research Fellowship at Pr Éric Oksenhendler Service, St-Louis Hospital, Paris, France

2013-present: Actively engaged in clinical practice, research, teaching, and professional development, making significant contributions to the field of allergy and clinical immunology.

Publications Noted & Contributions:

Boursiquot has made significant contributions to the medical literature through published articles, scientific posters, and presentations at conferences. His research has been focused on topics such as immunodeficiencies, allergic reactions, and treatment strategies. He has also engaged with the media to raise awareness and educate the public about allergies and related conditions.

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

  • Authors: Brillant-Marquis, F., Proulx, É., Ratnarajah, K., De Serres, G., Drolet, J.-P., Boursiquot, J.-N.
  • Journal: Journal of Allergy and Clinical Immunology: In Practice, 2024, 12(2), pp. 451–457.e2
  • Abstract: [Not available]
  • Citations: 1
  • Note: Open access

A Patient Charter for Chronic Urticaria

  • Authors: Maurer, M., Albuquerque, M., Boursiquot, J.-N., Nigen, S., Winders, T.
  • Journal: Advances in Therapy, 2024, 41(1), pp. 14–33
  • Abstract: [Not available]
  • Citations: 0
  • Review: Open access

Bradykinin-induced angioedema in the emergency department

  • Authors: Hébert, J., Boursiquot, J.-N., Chapdelaine, H., Lepeshkina, O., Vincent, M.
  • Journal: International Journal of Emergency Medicine, 2022, 15(1), 15
  • Abstract: [Not available]
  • Citations: 2
  • Erratum: Open access

Erratum: The International/Canadian Hereditary Angioedema Guideline

  • Authors: Betschel, S., Badiou, J., Binkley, K., Stark, D., Tsai, E.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 16
  • Abstract: [Not available]
  • Citations: 1
  • Erratum: Open access

Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: A parallel physician-patient survey

  • Authors: Ellis, A.K., Boursiquot, J., Carr, S., Graham, F., Masse, M.-S.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 15
  • Abstract: [Not available]
  • Citations: 8